....this one ending with Pfizer and American Lung Association logos. Get the BLA filed and sell to Pfizer, who will spend the gazillions in advertising that NVAX will never be able to afford to market the vaccine.
Let's see. Here's the past several months news - dilution via the Convertible offering, Erck's stock sales, Employee stock option plan dilution. Shareholders have been handed a sh_t sandwich while the share price is at penny stock levels.
....well stated. And yet here we sit at $5.00 Mind boggling. Another 4 or 5 months(I think NVAX will have results in August so I go with 4 months) and I believe the agony will end and the ecstasy will begin. If results are good, I don't see how NVAX remains independent given Big Pharma's desperate need for new revenue.
...is this company tone deaf?? Regardless of the huge potential, the current narrative is simply horrible.
....what else is there to say regarding the miserable price action as the S & P approaches historical highs and the IBB and XBI both outperform NVAX. Regardless of the huge potential, the recent narrative has been simply horrible, dominated by the Convertible offering and Erck's stock sale. Hoping for some positive news, otherwise we are stuck in the penalty box until Phase 3 results.
Medimmune was put in play by Carl Icahn. The combo RSV/Flu is years away from commercialization. And if Phase 3 is successful, NVAX would likely deem $25.00 to be too low.
"Its a big year for us. This will be a historic result in older adults"
Sounds pretty confident to me.
I would say it is a sure bet that the presentation at the conference tomorrow will be the same boilerplate as the most recent conference.
You are dreaming if you think otherwise.
I say SO WHAT.....Mers, Ebola, Bird Flu, etc. Tell me what exactly that has done for NVAX??